Position in VERU
as of Jun 30, 2026
· filed Jul 8, 2026
Position Value
$328,903
+$307,577 QoQ
Shares Held
105,081
+2757.8% QoQ
Ownership
0.616%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#10
of 61 holders
Holding Since
Mar 2022
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VERU Over Time
Shares Held
Position Value (USD)
Derivatives in VERU
reported options exposure · as of Dec 31, 2022CallValue
$105
CallShares
2
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026FNY Investment Advisers, LLC holds $19,945,542 across 57 Biotechnology names. VERU ranks #7 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | 108,951 | $13,455,448 | |||
| 2 | ABVX |
Abivax S.A.
|
7,605 | $1,013,442 | |
| 3 | SGMT |
Sagimet Biosciences Inc.
|
109,250 | $844,502 | |
| 4 | APGE |
Apogee Therapeutics, Inc.
|
5,000 | $663,650 | |
| 5 | JANX |
Janux Therapeutics, Inc.
|
30,850 | $473,856 | |
| 6 | NKTR |
Nektar Therapeutics
|
5,500 | $383,955 | |
| 7 | VERU |
Veru Inc.
This page
|
105,081 | $328,903 | |
| 8 | VKTX |
Viking Therapeutics, Inc.
|
8,170 | $318,711 |
All Filings in VERU
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $328,903 | 105,081 | Shares | Sole | 2026-07-08 | |
| 2025-06-30 | $21,326 | 36,769 | Shares | Defined | 2025-07-30 | |
| 2025-03-31 | $9,643 | 19,680 | Shares | Defined | 2025-04-17 | |
| 2022-12-31 | $105 | 20 | Call | Sole | 2023-01-10 | |
| 2022-09-30 | $230 | 20 | Call | Sole | 2022-10-19 | |
| 2022-09-30 | $11,520 | 1,000 | Shares | Sole | 2022-10-19 | |
| 2022-06-30 | $39,550 | 3,500 | Shares | Sole | 2022-07-12 | |
| 2022-06-30 | $1,808 | 160 | Put | Sole | 2022-07-12 | |
| 2022-06-30 | $3,164 | 280 | Call | Sole | 2022-07-12 | |
| 2022-03-31 | $483 | 100 | Call | Sole | 2022-04-25 | |
| No filing history on record for this holder in this stock. | ||||||